A Collaborative Study to Establish the 2nd International Standard for Fibrinogen, Plasma

Summary

An International Collaborative Study involving 12 laboratories in 7 different countries was undertaken in order to replace the 1st International Standard (IS) for Fibrinogen, Plasma (89/644). The candidate replacement standard was the ampouled and freeze-dried residue of solvent/detergent treated plasma and was calibrated as coded duplicates (A and B) versus the 1st IS Fibrinogen, Plasma by automated Clauss assay and by a recommended clot collection (gravimetric) assay. This latter method had been used to calibrate the 1st IS Fibrinogen, Plasma.

Comparing the ratios of the potency estimates of sample A to sample B (the coded duplicates), all of the laboratories obtained a ratio within 5% of the expected value of 1.0 by automated Clauss assay, which suggests that the laboratories were able to perform this assay well. Scrutiny of the data obtained from the gravimetric assays revealed that in almost all cases the results were invalid. The results of these assays are included in this report but clearly should be treated with caution and indeed produced significantly lower mean estimates of potency than the other assay methods. The overall geometric mean of all estimates of potency of the proposed 2nd IS Fibrinogen, Plasma (98/612) is 2.19 mg/ampoule by the automated Clauss assay. These data have been presented to the Fibrinogen Sub-Committee of the Standardisation and Scientific Committee (SSC) of the International Society on Thrombosis and Haemostasis (ISTH) (Washington, DC, August 1999), which recommended the establishment of 98/612 as the 2nd IS Fibrinogen, Plasma. This report has been presented to the Expert Committee on Biological Standardisation of the World Health Organisation (ECBS-WHO) at their 1999 session and 98/612 was established as the 2nd IS Fibrinogen, Plasma with a potency of 2.2 mg/ ampoule.

Keywords

Fibrinogen - Clauss assay - plasma - International Standard

• References

• 1 Rampling MW, Gaffney PJ. Measurement of fibrinogen in plasma. In: Prog Chemical/Fibrinolysis and Thrombosis. Davidson JF, Samama MM, Desnoyers PC. New York: Raven Press; 1976. vol. 02 91-105.
• 2 Meade TW. Hypercoagulability and ischaemic heart disease. Blood Rev 1987; 01: 2-8.
• 3 Furlan M, Felix R, Escher N, Lämmle B. How high is the true fibrinogen content of fibrinogen standards?. Thromb Res 1989; 56: 583-92.
• 4 Gaffney PJ, Wong MY. Collaborative study of a proposed international standard for plasma fibrinogen measurement. Thromb Haemost 1992; 68 (04) 428-32.
• 5 Campbell PJ. International biological standards and reference preparations. 1. Preparation and presentation of materials to serve as standards and reference preparations. J Biol Stand 1974; 02: 249-58.
• 6 Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 1959; 17: 237-46.
• 7 Hoegee-de Nobel E, Voskuilen M, Briët E, Brommer EJP, Nieuwenhuizen W. A monoclonal antibody-based quantitative enzyme immunoassay for the determination of plasma fibrinogen concentrations. Thromb Haemost 1988; 60: 415-8.
• 8 Finney DJ. Statistical methods in biological assay. 3rd edn. London: Charles Griffin; 1978
• 9 Kirkwood TBL. Geometric means and measures of dispersion. Biometrics 1979; 35: 908-9.
• 10 Jacobsson K. Studies in the determination of fibrinogen in human blood plasma. Scand J Clin Lab Invest 1955; 07 (Suppl. 14) 1-54.
• 11 Kirkwood TBL. Design and analysis of accelerated degradation tests for the stability of biological standards III, principles of design. J Biol Stand 1984; 12: 215-24.
• 12 Gaffney PJ. Structure of fibrinogen and degradation products of fibrinogen and fibrin. Br Med Bull 1977; 33: 245-52.